![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Salvia miltiorrhiza - Wikipedia
Salvia miltiorrhiza (Chinese: 丹參; pinyin: dānshēn), also known as red sage, redroot sage, Chinese sage, or danshen, is a perennial plant in the genus Salvia, highly valued for its roots in traditional Chinese medicine. [2]
What Is Red Sage? Benefits, Uses and Side Effects - Dr. Axe
2020年4月14日 · Salvia miltiorrhiza Bunge, also known as red sage or Danshen (or Dan Shen), is a perennial plant in the mint family, like common sage. It’s native to China and Japan, and the dried red roots of the plant are used for medicine.
12+ Benefits of Salvia miltiorrhiza Root (Danshen)
2022年12月15日 · Salvia miltiorrhiza is used for promoting blood flow and heart health in Traditional Chinese Medicine. Learn about the latest research here.
Salvia miltiorrhiza: Traditional medicinal uses, chemistry ...
Salvia miltiorrhiza Bunge (SM) is a very popular medicinal plant that has been extensively applied for many years to treat various diseases, especially coronary heart diseases and cerebrovascular diseases, either alone or in combination with other Chinese plant-based medicines.
Salvia miltiorrhiza: A Potential Red Light to the Development ...
Salvia miltiorrhiza Bunge, also known as Danshen in Chinese, has been widely used to treat cardiovascular diseases (CVD) in China and other Asia countries. Here, we summarize literatures of the historical traditional Chinese medicine (TCM) ...
Salvia Miltiorrhiza - an overview | ScienceDirect Topics
Salvia miltiorrhiza is a well-known traditional perennial plant used in Chinese, Korean, and Japanese medicine to treat diabetes and its related chronic conditions for over a thousand years.
Salvia miltiorrhiza
2018年4月26日 · Salvia miltiorrhiza Burge (Danshen) is an eminent medicinal herb that possesses broad cardiovascular and cerebrovascular protective actions and has been used in Asian countries for many...
Expanding the therapeutic potential of Salvia miltiorrhiza: a ...
Salvia miltiorrhiza has been widely used in clinical non-surgical treatment of early and middle stage femoral head necrosis, with therapeutic effect that can improve ON-FH symptoms in patients and delay disease progression (Wang et al., 2010).